MedCap AB (publ) (STO:MCAP)

Sweden flag Sweden · Delayed Price · Currency is SEK
467.40
-10.80 (-2.26%)
Apr 28, 2026, 5:29 PM CET
12.49%
Market Cap 7.18B
Revenue (ttm) 2.11B
Net Income (ttm) 219.80M
Shares Out 15.02M
EPS (ttm) 14.67
PE Ratio 32.60
Forward PE 26.13
Dividend n/a
Ex-Dividend Date n/a
Volume 20,037
Average Volume 11,288
Open 482.60
Previous Close 478.20
Day's Range 456.00 - 484.00
52-Week Range 393.00 - 677.00
Beta 0.51
RSI 38.40
Earnings Date Apr 29, 2026

About MedCap AB

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals; MedTech including healthcare equipment, software, components, and packaging solutions for life science products; and Assistive Tech including digital and physical solutions in cognition, communication, environmental control, alarms, mobility, accessibility, and orth... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2001
Employees 637
Stock Exchange Nasdaq Stockholm
Ticker Symbol MCAP
Full Company Profile

Financial Performance

In 2025, MedCap AB's revenue was 2.11 billion, an increase of 16.73% compared to the previous year's 1.81 billion. Earnings were 219.80 million, an increase of 5.98%.

Financial Statements

News

What To Expect From MedCap AB (OSTO:MCAP) Q4 2025 Earnings

What To Expect From MedCap AB (OSTO:MCAP) Q4 2025 Earnings

2 months ago - GuruFocus